Message Font: Serif | Sans-Serif
No. of Recommendations: 0
UNITED STATES SURGICAL CORP. (USS) (NYSE: USS) announced that the Court of Appeals for the Federal Circuit in Washington, DC, has again affirmed the dismissal of Ethicon, Inc.'s entire trocar patent infringement claim against USS. Ethicon, a JOHNSON & JOHNSON (NYSE: JNJ) company, had requested reconsideration by the Court of Appeals. The Court's denial of Ethicon's combined petition for rehearing and suggestion for rehearing en banc (before the entire panel of judges) now clears the way for USS to proceed on its own patent infringement claims against Ethicon. USS has claimed that Ethicon is infringing three of its trocar patents. The Ethicon patents at issue include all of the safety-shielded trocars sold by Ethicon since their introductions in 1990. If USS prevails, damages could exceed $500 million before trebling. USS has requested a prompt trial date from the District Court in Hartford to hear its patent infringement claims against Ethicon.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.